首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Evaluation of clinical pharmacy services offered for palliative care patients in Qatar
【24h】

Evaluation of clinical pharmacy services offered for palliative care patients in Qatar

机译:为卡塔尔的姑息治疗患者提供的临床药房服务评估

获取原文
获取原文并翻译 | 示例
       

摘要

Palliative care is an emerging concept in the countries of the Gulf Cooperation Council, a political and economic union of Arab states bordering the Persian Gulf, namely Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. Clinical pharmacy services have not yet been evaluated in this region. The objectives of this study were to create a baseline inventory of clinical pharmacy interventions in palliative care and to assess the perceived importance of interventions made. This was a prospective, single-center characterization study. Interventions were documented from September 30 to December 1, 2013. They were characterized into predetermined categories and analyzed using descriptive statistics. Physician acceptance rate and intervention rate per patient were calculated. Classification categories were sent to 10 practicing pharmacists in each of Qatar and Canada, who ranked the categories on the basis of perceived importance. A total of 96 interventions were documented, giving 3 interventions per patient and an acceptance rate of 81%. Discontinuing therapy (29%), initiating therapy (25%), and provision of education/counseling (13.5%) were most common. No differences were found between rankings from pharmacists in Qatar or Canada. Clinical pharmacy interventions are frequent, and those relating to alterations in drug therapy are most common. Interventions align with the perceived importance from pharmacists in both Qatar and Canada.
机译:姑息治疗在海湾合作委员会国家中是一个新兴概念,海湾合作委员会是与波斯湾接壤的阿拉伯国家的政治和经济联盟,这些国家是巴林,科威特,阿曼,卡塔尔,沙特阿拉伯和阿拉伯联合酋长国。该地区尚未评估临床药学服务。这项研究的目的是建立姑息治疗中临床药学干预措施的基线清单,并评估所采取干预措施的重要性。这是一项前瞻性,单中心表征研究。干预记录于2013年9月30日至12月1日。它们被分类为预定类别并使用描述性统计数据进行了分析。计算了每个患者的医师接受率和干预率。将分类类别发送给卡塔尔和加拿大的10名执业药师,他们根据感知到的重要性对类别进行排名。总共记录了96项干预措施,每位患者进行3项干预措施,接受率为81%。终止治疗(29%),开始治疗(25%)和提供教育/咨询(13.5%)最为常见。在卡塔尔或加拿大的药剂师排名之间没有发现差异。临床药学干预很常见,与药物治疗改变有关的干预最为常见。干预措施与卡塔尔和加拿大药剂师认为的重要性相吻合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号